FEops HEARTguide

FEops HEARTguide leverages patient-specific cardiac CT data and finite element analysis to simulate LAAO device deployment, providing predictive insights for optimized pre-procedural planning. This computational approach aims to improve device selection and placement, thereby potentially enhancing clinical outcomes and reducing complications in structural heart interventions.

FEops HEARTguide is an advanced software tool designed for pre-procedural planning in structural heart interventions, with a primary application in left atrial appendage occlusion (LAAO). The methodology involves using a patient's pre-operative cardiac CT scan to generate a patient-specific 3D anatomical model. On this model, the system performs finite element analysis (FEA) to simulate the deployment of a selected LAAO device. This simulation predicts critical factors such as the device's final shape, its apposition to the cardiac tissue, and the presence of any potential residual gaps, which are crucial for selecting the optimal device size and implantation strategy. The science behind HEARTguide lies in its ability to translate complex anatomical data and biomechanical principles into actionable clinical insights. By automating the image segmentation process and conducting mechanical simulations in a cloud environment, it provides clinicians with detailed visualizations. Retrospective studies have demonstrated a strong correlation between these predictive simulations and actual post-procedural outcomes observed clinically. This suggests that HEARTguide can significantly enhance the precision of pre-operative planning, potentially leading to a reduction in procedural complications and improved patient safety by allowing for more informed decision-making before the intervention occurs.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does FEops HEARTguide account for dynamic cardiac motion and tissue properties beyond what is captured in a static pre-procedural CT scan?; What is the quantitative impact of using FEops HEARTguide on procedural times, contrast use, and fluoroscopy exposure compared to standard planning methods?; Are there specific patient anatomical variations or device types where FEops HEARTguide's predictive accuracy has been shown to be significantly higher or lower?; How does the cloud-based automated segmentation and simulation process ensure patient data privacy and security?; Beyond device sizing and apposition, can FEops HEARTguide predict potential long-term complications, such as device-related thrombus or peri-device leak evolution?